Regsurance

Endocrine Disruptor Assessment Under CLP: Key Challenges and How We Delivered a Robust, Regulator-Ready Outcome

CLP New Hazards

Under CLP Delegated Regulation (EU) 2023/707, companies must assess whether substances meet criteria for endocrine disruption in humans (ED HH) or the environment (ED ENV). This post outlines how RegSurance conducted a full ED assessment for a high-volume industrial chemical using a transparent weight-of-evidence approach aligned with EFSA–ECHA Guidance 2018, resulting in a defensible, non-classification […]